ESSILORLUXOTTICA AND DIESELANNOUNCE A TEN-YEAR LICENSING AGREEMENT Charenton-le-Pont, France and Milan, Italy (18 June 2024) – EssilorLuxottica and Diesel announced…
NEW YORK, June 19, 2024 /PRNewswire/ -- The global biobanking market size is estimated to grow by USD 1.66 billion from…
With five pioneering & established clinics in Dubai, the new state-of-the-art clinic will open in Abu Dhabi in the third…
IPSWICH, Mass. and PARIS, June 18, 2024 /PRNewswire/ -- New England Biolabs (NEB ®) and Inorevia announce a collaboration to…
EpiFinder™ Platform generates quantitative data at scale, with unprecedented speed and cost-efficiencyEpiFinder Genome generates 192 genome-wide profiles by simultaneously targeting up…
Partnership Will Aid Physicians in Precision Prescribing Decisions Based on Applied DNA's TR8™ Pharmacogenomic (PGx) Test STONY BROOK, NY /…
First Quarter Revenue Increased 30.2% and Gross Profit Increased 159.8% from Prior Year Quarter Confirms Strategic Pivot Targeting the U.S.…
MINNEAPOLIS, MN, June 18, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”), today announced…
– Phase 1b study will evaluate safety, pharmacokinetic and efficacy endpoints in participants with chronic hepatitis B virus infection with…
The first five patients successfully completed protocols with no immediate procedural-related complications or significant adverse events; Pain relief for responder…